Register      Login
Wildlife Research Wildlife Research Society
Ecology, management and conservation in natural and modified habitats
RESEARCH ARTICLE

Fertility control in female eastern grey kangaroos using the GnRH agonist deslorelin. 1. Effects on reproduction

C. A. Herbert A C , T. E. Trigg B and D. W. Cooper A
+ Author Affiliations
- Author Affiliations

A School of Biological, Earth & Environmental Sciences, University of New South Wales, Sydney, NSW 2052, Australia.

B Peptech Animal Health Pty Limited, Locked Bag No. 2053, Macquarie Park, NSW 1670, Australia.

C Corresponding author. Email: cathherbert@unsw.edu.au

Wildlife Research 33(1) 41-46 https://doi.org/10.1071/WR04113
Submitted: 9 November 2004  Accepted: 23 November 2005   Published: 7 March 2006

Abstract

Eastern grey kangaroos are widespread on the east coast of Australia and frequently reach high densities in reserves and parkland near urban areas. Management of these populations is highly contentious and non-lethal fertility-control technologies are sought as an alternative option to manage population size. This study evaluated the potential of slow-release gonadotrophin-releasing hormone agonist (deslorelin) implants to inhibit reproduction in female kangaroos. Deslorelin treatment effectively inhibited reproduction in adult females for periods of 559 ± 111 days (n = 6) and 651 ± 21 days (n = 5) after administration of one or two 10-mg implants respectively. Animals treated with the lower dosage tended to resume breeding earlier than those that received a total of 20 mg of deslorelin (minimum duration of 18 months). Deslorelin treatment had no effect on blastocyst reactivation in a single treated female and repeat treatment had no negative side-effects. This study has demonstrated that slow-release deslorelin implants can successfully inhibit reproduction for extended periods in the female eastern grey kangaroos. This approach may have potential application in reproductive management of problem kangaroo populations.


Acknowledgments

This project would not have been possible without the support of Ron Claassens, Anne Mouland and James Cook, whose expertise in macropod handling and husbandry made it possible to work with these animals. Numerous volunteers assisted with the husbandry of the animals. Thank you to Peptech Animal Health Pty Ltd for the generous supply of deslorelin implants. This project was supported by an ARC SPIRT grant awarded to DWC (C00001980). CAH was the recipient of an Australian Postgraduate Award.


References

Adderton Herbert, C. (2004). Long-acting contraceptives: a new tool to manage overabundant kangaroo populations in nature reserves and urban areas. Australian Mammalogy 26, 67–74.
Brown J. L., and Jöchle W. (2001). Use of Deslorelin to suppress estrous cyclicity in elephants: importance of endocrine monitoring to assess efficacy. In ‘5th International Symposium on Fertility Control in Wildlife Management’, Skukuza, Kruger National Park, South Africa, 19–22 August 2001. (Ed. J. F. Kirkpatrick.) pp. 20–21.

DeNicola, A. J. , Kesler, D. J. , and Swihart, R. K. (1997). Dose determination and efficacy of remotely delivered norgestomet implants on contraception of white-tailed deer. Zoo Biology 16, 31–37.
Crossref | GoogleScholarGoogle Scholar | National Health and Medical Research Council of Australia (1997). ‘Australian Code of Practice for the Care and Use of Animals for Scientific Purposes.’ (Australian Government Publishing Service: Canberra, ACT.)

Nave C. D. (2002). Fertility control in the eastern grey kangaroo, Macropus giganteus. Ph.D. Thesis, The University of Melbourne.

Nave, C. D. , Shaw, G. , Short, R. V. , and Renfree, M. B. (2000). Contraceptive effects of levonorgestrel implants in a marsupial. Reproduction, Fertility and Development 12, 81–86.
Crossref | GoogleScholarGoogle Scholar | Rose K. (1999). Common diseases of urban wildlife. In ‘Wildlife in Australia: Healthcare and Management’. (Ed. D. I. Bryden.) pp. 365–430. Post Graduate Foundation in Veterinary Science, University of Sydney.

Spearow, J. L. , Doemeny, P. , Sera, R. , Leffler, R. , and Barkley, M. (1999). Genetic variation in susceptibility to endocrine disruption by estrogen in mice. Science 285, 1259–1261.
Crossref | GoogleScholarGoogle Scholar | PubMed | Tyndale-Biscoe C. H., and Renfree M. B. (1987). ‘Reproductive Physiology of Marsupials.’ (Cambridge University Press: Cambridge, UK.)

Vogelnest L. (1999). Chemical restraint of Australian native fauna. In ‘Wildlife in Australia: Healthcare and Management’. (Ed. D. I. Bryden.) pp. 149–188. Post Graduate Foundation in Veterinary Science, University of Sydney.

Wallen, K. , Mann, D. R. , Davis-DaSilva, M. , Gaventa, S. , Lovejoy, J. C. , and Collins, D. C. (1986). Chronic gonadotropin-releasing hormone agonist treatment suppresses ovulation and sexual behavior in group-living female rhesus monkeys. Physiology & Behavior 36, 369–375.
Crossref | GoogleScholarGoogle Scholar | PubMed | Walsh J. D., and Trigg T. E. (2001). Formulations for peptide release. In ‘United States Patent and Trademark Office’. (Peptech Ltd: Waltham, MA.)

Winslow, K. L. , Gordon, K. , Williams, R. F. , and Hodgen, G. D. (1992). Interval required for gonadotropin-releasing hormone-agonist-induced down regulation of the pituitary in cynomolgus monkeys and duration of the refractory state. Fertility and Sterility 58, 1209–1214.
PubMed |

Woodward, R. , Herberstein, M. E. , and Herbert, C. A. (2006). Fertility control in female eastern grey kangaroos using the GnRH agonist deslorelin. 2. Effects on behaviour. Wildlife Research 33, 47–55.